In CML, a study by Li et al. (2018b) showed that MEG3 interacted with miR-184 to downregulate related proteins and reduce cell proliferation and invasion. This evidence concerns the gene MEG3 and chronic myelogenous leukemia, BCR-ABL1 positive.